FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386046279> ?p ?o ?g. }

• W4386046279 abstract "Abstract Background Small cell lung cancer (SCLC) is a neuroendocrine tumor with poor prognosis. Neuroendocrine tumors possess characteristics of both nerve cells and hormone‐secreting cells; therefore, targeting the neuronal properties of these tumors may lead to the development of new therapeutic options. Among the endogenous signaling pathways in the nervous system, targeting the glutamate pathway may be a useful strategy for glioblastoma treatment. Perampanel, an antagonist of the synaptic glutamate α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptor (AMPAR), has been reported to be effective in patients with glioblastoma. In this study, we aimed to investigate the antitumor effects of AMPAR antagonists in human SCLC cell lines. Methods We performed to examine the expression of AMPAR using Western blot and immunohistochemical analysis. The antitumor effects of AMPAR antagonists on human SCLC cell lines were investigated in vitro and in vivo. We also analyzed the signaling pathway of AMPAR antagonists in SCLC cell lines. Statistical analysis was performed by the GraphPad Prism 6 software. Results We first examined the expression of endogenous AMPAR in six human SCLC cell lines, detecting AMPAR proteins in all of them. Next, we tested the anti−proliferative effect of two AMPAR antagonists, talampanel and cyanquixaline, using SCLC cells in vitro and in vivo. Both AMPAR antagonists inhibited cell proliferation and mitogen‐activated protein kinase (MAPK) phosphorylation in SCLC cells in vitro. Further, we observed reduced proliferation of implanted cell lines in an in vivo setting, assessed by Ki‐67 immunohistochemistry. Additionally, using immunohistochemical analysis we confirmed AMPAR protein expression in human SCLC samples. Conclusion AMPAR may be a potential therapeutic target for SCLC." @default.
• W4386046279 created "2023-08-23" @default.
• W4386046279 creator A5005264920 @default.
• W4386046279 creator A5014522211 @default.
• W4386046279 creator A5014708941 @default.
• W4386046279 creator A5033639125 @default.
• W4386046279 creator A5033747627 @default.
• W4386046279 creator A5041864474 @default.
• W4386046279 creator A5043573908 @default.
• W4386046279 creator A5054367448 @default.
• W4386046279 creator A5059935709 @default.
• W4386046279 creator A5061041118 @default.
• W4386046279 creator A5086189625 @default.
• W4386046279 date "2023-08-22" @default.
• W4386046279 modified "2023-10-15" @default.
• W4386046279 title "<scp>AMPAR</scp> receptor inhibitors suppress proliferation of human small cell lung cancer cell lines" @default.
• W4386046279 cites W1491616134 @default.
• W4386046279 cites W1524992328 @default.
• W4386046279 cites W1544008935 @default.
• W4386046279 cites W1545238849 @default.
• W4386046279 cites W1836062014 @default.
• W4386046279 cites W1966669109 @default.
• W4386046279 cites W1969942127 @default.
• W4386046279 cites W1980642537 @default.
• W4386046279 cites W1982195853 @default.
• W4386046279 cites W1984660568 @default.
• W4386046279 cites W1991547423 @default.
• W4386046279 cites W2025160847 @default.
• W4386046279 cites W2025797846 @default.
• W4386046279 cites W2031075138 @default.
• W4386046279 cites W2039906334 @default.
• W4386046279 cites W2063461600 @default.
• W4386046279 cites W2071832447 @default.
• W4386046279 cites W2073245622 @default.
• W4386046279 cites W2077776183 @default.
• W4386046279 cites W2082805232 @default.
• W4386046279 cites W2097333265 @default.
• W4386046279 cites W2102085111 @default.
• W4386046279 cites W2169578249 @default.
• W4386046279 cites W2256190006 @default.
• W4386046279 cites W2294521703 @default.
• W4386046279 cites W2513779190 @default.
• W4386046279 cites W2618580991 @default.
• W4386046279 cites W2809877895 @default.
• W4386046279 cites W2904194603 @default.
• W4386046279 cites W2914612812 @default.
• W4386046279 cites W2936622381 @default.
• W4386046279 cites W2973686658 @default.
• W4386046279 cites W2974724557 @default.
• W4386046279 cites W3154891659 @default.
• W4386046279 cites W3163711131 @default.
• W4386046279 cites W3214266442 @default.
• W4386046279 cites W4386046279 @default.
• W4386046279 doi "https://doi.org/10.1111/1759-7714.15075" @default.
• W4386046279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37605807" @default.
• W4386046279 hasPublicationYear "2023" @default.
• W4386046279 type Work @default.
• W4386046279 citedByCount "0" @default.
• W4386046279 crossrefType "journal-article" @default.
• W4386046279 hasAuthorship W4386046279A5005264920 @default.
• W4386046279 hasAuthorship W4386046279A5014522211 @default.
• W4386046279 hasAuthorship W4386046279A5014708941 @default.
• W4386046279 hasAuthorship W4386046279A5033639125 @default.
• W4386046279 hasAuthorship W4386046279A5033747627 @default.
• W4386046279 hasAuthorship W4386046279A5041864474 @default.
• W4386046279 hasAuthorship W4386046279A5043573908 @default.
• W4386046279 hasAuthorship W4386046279A5054367448 @default.
• W4386046279 hasAuthorship W4386046279A5059935709 @default.
• W4386046279 hasAuthorship W4386046279A5061041118 @default.
• W4386046279 hasAuthorship W4386046279A5086189625 @default.
• W4386046279 hasBestOaLocation W43860462791 @default.
• W4386046279 hasConcept C126322002 @default.
• W4386046279 hasConcept C150903083 @default.
• W4386046279 hasConcept C160268369 @default.
• W4386046279 hasConcept C170493617 @default.
• W4386046279 hasConcept C207001950 @default.
• W4386046279 hasConcept C502942594 @default.
• W4386046279 hasConcept C54355233 @default.
• W4386046279 hasConcept C55493867 @default.
• W4386046279 hasConcept C57074206 @default.
• W4386046279 hasConcept C61174792 @default.
• W4386046279 hasConcept C62112901 @default.
• W4386046279 hasConcept C62478195 @default.
• W4386046279 hasConcept C71924100 @default.
• W4386046279 hasConcept C81885089 @default.
• W4386046279 hasConcept C86803240 @default.
• W4386046279 hasConcept C95444343 @default.
• W4386046279 hasConcept C98274493 @default.
• W4386046279 hasConceptScore W4386046279C126322002 @default.
• W4386046279 hasConceptScore W4386046279C150903083 @default.
• W4386046279 hasConceptScore W4386046279C160268369 @default.
• W4386046279 hasConceptScore W4386046279C170493617 @default.
• W4386046279 hasConceptScore W4386046279C207001950 @default.
• W4386046279 hasConceptScore W4386046279C502942594 @default.
• W4386046279 hasConceptScore W4386046279C54355233 @default.
• W4386046279 hasConceptScore W4386046279C55493867 @default.
• W4386046279 hasConceptScore W4386046279C57074206 @default.
• W4386046279 hasConceptScore W4386046279C61174792 @default.
• W4386046279 hasConceptScore W4386046279C62112901 @default.
• W4386046279 hasConceptScore W4386046279C62478195 @default.

• next